VisomitinDry eye syndrome; moderate-to-severe
New molecular entity
Development and Regulatory status
Phase III Clinical Trials
Reduces oxidative stress inside mitochondria, preserving them and improving dry eye. 
Dry eye syndrome is a common condition affecting 15-33% of those aged over 65 years. Prevalence increases with age. It is 50% more common in women than in men.
Dry eye syndrome; moderate-to-severe